Vlasta Bradamante
Overview
Explore the profile of Vlasta Bradamante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vuksic A, Rasic D, Zunec S, Bozina T, Konjevoda P, Lovric J, et al.
Arh Hig Rada Toksikol
. 2023 Apr;
74(1):34-41.
PMID: 37014683
The objective of study was to investigate the effects of different doses of simvastatin and fenofibrate on malondialdehyde (MDA) and reduced glutathione (GSH) in the plasma, liver, and brain tissue...
2.
Vuksic A, Lovric J, Konjevoda P, Blazevic N, Bilusic M, Bradamante V
Arh Hig Rada Toksikol
. 2019 Apr;
70(1):30-35.
PMID: 30956215
The study objective was to test the hypothesis that simvastatin and fenofibrate should cause an increase in butyrylcholinesterase (BuChE) activity not only in the plasma and liver but also in...
3.
Macan M, Vuksic A, Zunec S, Konjevoda P, Lovric J, Kelava M, et al.
Pharmacol Rep
. 2015 Sep;
67(5):907-13.
PMID: 26398384
Background: We investigated the possible non-lipid effects of simvastatin (SIMV) on paraoxonase 1 (PON1) and butyrylcholinesterase (BuChE) activity, as well as on malondialdehyde (MDA) levels in normolipidemic rats. Methods: Two...
4.
Borovecki A, Bradamante V, Simonovic D, Babic-Bosanac S
Lijec Vjesn
. 2011 May;
133(3-4):133-9.
PMID: 21612111
Informed consent represents the standard for adequate protection of all participants in biomedical research. This standard is affirmed in international legal documents concerning biomedical research, as well as in Croatian...
5.
Macan M, Marija M, Konjevoda P, Pasko K, Lovric J, Jasna L, et al.
Basic Clin Pharmacol Toxicol
. 2011 Jan;
108(6):428-35.
PMID: 21223511
There are diverse experimental data about the influence of gemfibrozil (GEM) on the production of hydrogen peroxide (H(2)O(2)) and antioxidant enzymes. We investigated the influence of GEM treatment on the...
6.
Macan M, Vrkic N, Lucic Vrdoljak A, Radic B, Bradamante V
Acta Biochim Pol
. 2010 Jun;
57(3):321-6.
PMID: 20548972
We investigated the influence of high sucrose diet (HSD) after 3 or 5 weeks of administration on paraoxonase 1 (PON1) activity in plasma of normolipidemic rats and the relationship between...
7.
Bozina N, Bradamante V, Lovric M
Arh Hig Rada Toksikol
. 2009 Jul;
60(2):217-42.
PMID: 19581216
The polymorphic P450 (CYP) enzyme superfamily is the most important system involved in the biotransformation of many endogenous and exogenous substances including drugs, toxins, and carcinogens. Genotyping for CYP polymorphisms...
8.
Muacevic-Katanec D, Bradamante V, Poljicanin T, Reiner Z, Babic Z, Simeon-Rudolf V, et al.
Arzneimittelforschung
. 2007 Dec;
57(10):647-53.
PMID: 18074758
Human paraoxonase (PON1) is a serum high-density lipoprotein-associated phosphotriesterase. High-density lipoprotein (HDL) plays the role of a carrier and the site of action of this enzyme. According to a majority...
9.
Bradamante V, Krnic Z, Zrinski R, Konjevoda P, Reiner Z
Arzneimittelforschung
. 2006 Apr;
56(2):64-9.
PMID: 16572919
The effects of chronic treatment with oxprenolol (CAS 6452-72-7, OXP, 15 mg/ kg/ day) or glibenclamide (CAS 10238-21-8, GL, 2.5 mg/kg/day), or their combination administered for 6 and 12 weeks,...
10.
Lucic Vrdoljak A, Bradamante V, Radic B, Peraica M, Fuchs R, Reiner Z
Acta Pharm
. 2005 Sep;
55(2):177-85.
PMID: 16179131
The paper describes the effect of glucocorticoid dexamethasone (DM) given intraperitoneally on the catalytic activity of butyrylcholinesterase (BuChE) measured in plasma, liver and white adipose tissue of rats of both...